Search results
1 day ago · Sam et al. describe a case study of a patient with Hodgkin’s lymphoma and papillary carcinoma diagnosed with depletion-associated prolonged acute COVID-19 treated with anti-SARS-CoV-2 the ...
May 8, 2024 · Remdesivir (Veklury, Gilead Sciences) is 'indicated for the treatment of coronavirus disease 2019 (COVID‑19) in: adults and paediatric patients (at least 4 weeks of age and weighing at least 3 kg) with pneumonia requiring supplemental oxygen (low- or high-flow oxygen or other non-invasive ventilation at start of treatment)
May 21, 2024 · COVID-19 treatments. The NHS is offering treatments to those people with COVID-19 who are at highest risk of becoming seriously ill and who are aged 12 years or above. Not all treatments are ...
May 11, 2024 · Remdesivir is a medicine that blocks the virus that causes COVID-19 from spreading in the body. It's used to treat COVID-19 in people age 12 and older. It's given through a needle into a vein, known as intravenously (IV). Molnupiravir. The FDA has authorized an antiviral drug called molnupiravir.
5 days ago · Methods. We conducted a phase 3, double-blind, randomized, placebo-controlled trial to evaluate the efficacy and safety of olgotrelvir in 1212 nonhospitalized adult participants with mild to moderate Covid-19, irrespective of risk factors, who were randomly assigned to receive orally either 600 mg of olgotrelvir or placebo twice daily for 5 days.
3 days ago · Post-acute sequelae of SARS CoV-2 infection (PASC), also referred to as Long COVID (LC) is a condition defined by persistent symptoms and/or long-term complications lasting over 4 weeks from the onset of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. 1,2 PASC has been subdivided into 2 categories: (1) current or subacute coronavirus disease of 2019 (COVID-19 ...
May 7, 2024 · The following treatments can be used in the EU to treat COVID-19: entries per page. Treatment. Status. More information. Showing 1 to 8 of 8 entries. «
